Table 1.

Clinical characteristics of HCC patients in Cohorts 1 and 2.

Parameter	Cohort 1 (n = 133)	Cohort 2 (n = 238)
Age (years, mean, SEM)	65.2, 0.9	50.7, 0.71
Sex (M/F)	99/34	208/30
AFP (ng/mL, median, 25–75%)	14, 10–198	184.4, 13.7–1629
BCLC stage (0-A, B-C, NA)	85/48/0	170/52/16
Virus (HBV/HCV/B + C/NBNC)	33/50/2/48	238/0/0/0
LC (yes/no)	71/62	219/19

AFP; alpha-fetoprotein, BCLC; Barcelona clinic liver cancer, HBV; hepatitis B virus, HCV; hepatitis C virus, NBNB; non-B non-C, LC; liver cirrhosis, NA; not available.